Genecast Biotechnology, a Chinese biotech firm that specialises in next-generation sequencing (NGS) technology and bioinformatics, has secured over 1 billion yuan ($149 million) in a Series E round of financing, the firm announced on Monday.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
